Oral Oncology
Volume 45, Issue 8 , Pages 669-674 , August 2009

Survival from salivary glands adenoid cystic carcinoma in European populations

  • Laura Ciccolallo

      Affiliations

    • Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 02 23903517/2900; fax: +39 02 23903522.
    • ,
  • Lisa Licitra

      Affiliations

    • Head and Neck Medical Oncology Unit, Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    • ,
  • Giulio Cantú

      Affiliations

    • Head and Neck Surgery Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    • ,
  • Gemma Gatta

      Affiliations

    • Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    • ,
  • the EUROCARE Working Group

      Affiliations

    • EUROCARE Working Group: Austria: W Oberaigner (Tyrol Cancer Registry); Denmark: HH Storm (Danish Cancer Society, Dept. Cancer Prevention and Documentation); Estonia: T Aareleid (Estonian Cancer Registry); Czech Republic: M Jechova, M Rousarova (IHIS and West Bohemia Cancer Registry); Finland: T Hakulinen (Finnish Cancer Registry); France: G Hédelin (Bas-Rhin Cancer Registry), I Tron, E Le Gall (Bretagne Childhood Cancer Registry), G Launoy (Calvados Digestive Cancer Registry), J Macé-Lesec’h (Calvados General Cancer Registry), J Faivre (Côte d’Or Digestive Cancer Registry), G Chaplain (Côte d’Or Gynaecologic Cancer Registry), P-M Carli (Côte d’Or Malignant Haemopathies Registry), A Danzon (Doubs Cancer Registry), B Tretarre (Hérault Cancer Registry), M Colonna (Isère Cancer Registry), B Lacour (Lorraine Childhood Cancer Registry), N Raverdy (Somme Cancer Registry), C Berger, B. Freycon (Rhône-Alpes Childhood Registry), P Grosclaude (Tarn Cancer Registry), J Estève (University of Lyon); Germany: P Kaatsch (German Childhood Cancer Registry), H Ziegler (Saarland Cancer Registry), D Hölzel, G Schubert Fritschle (Munich Cancer Registry); Iceland: L Tryggvadottir (Icelandic Cancer Registry); Italy: F Berrino (Project Leader), C Allemani, P Baili, L Ciccolallo, P Crosignani, G Gatta, A Micheli, M Sant, E Taussig,S Sowe, (Istituto Nazionale per lo Studio e la Cura dei Tumori, Lombardy Cancer Registry), S Ferretti (Ferrara Cancer Registry), E Conti (Latina Cancer Registry), M Vercelli, A Quaglia (Liguria Region Cancer Registry–DOBIG Univ. GE, IST Genova), F Pannelli (Macerata Cancer Registry, Marche Childhood Cancer Registry), M Federico, ME Artioli (Modena Cancer Registry), M Ponz De Leon, P Benatti (Modena Colorectal Cancer Registry), V De Lisi, L Servente (Parma Cancer Registry), R Zanetti, S Patriarca (Piedmont Cancer Registry), C Magnani, G Pastore (Piedmont Childhood Cancer Registry), L Gafà, R Tumino (Ragusa Cancer Registry), F Falcini (Romagna Cancer Registry), M Budroni (Sassari Cancer Registry), E Paci, E Crocetti (Tuscan Cancer Registry), P Zambon, S Guzzinati (Venetian Cancer Registry), R Capocaccia, E Carrani, R De Angelis, P Roazzi, M Santaquilani, A Tavilla, F Valente, A Verdecchia (Istituto Superiore di Sanità, Rome); Malta: M Dalmas (Malta National Cancer Registry); Norway: F Langmark, A Andersen (Cancer Registry of Norway, Institute of Population-based Cancer Research); Poland: J Rachtan (Cracow Cancer Registry), M Bielska–Lasota, Z Wronkowski (Warsaw Cancer Registry); Slovakia: I Pleško, A Obsitníková (National Cancer Registry of Slovakia); Slovenia: V Pompe–Kirn, Maja Primic Žakelj (Cancer Registry of Slovenia); Spain: I Izarzugaza (Basque Country Cancer Registry), C Martinez-Garcia (Granada Cancer Registry), I Garau (Mallorca Cancer Registry), C Navarro, MD Chirlaque (Murcia Cancer Registry), E Ardanaz, C Moreno (Navarra Cancer Registry), J Galceran (Tarragona Cancer Registry), A Torrella (Childhood Tumor Registry of Valencia), R Peris-Bonet (National Childhood Cancer Registry and Instituto Lopez Pinero, Valencia); Sweden: L Barlow, T Möller (Cancer Registry of Sweden); Switzerland: G Jundt (Basel Cancer Registry), JM Lutz, C Bouchardy (Geneva Cancer Registry); The Netherlands: JWW Coebergh (Eindhoven Cancer Registry), O Visser (Amsterdam Cancer Registry); UK - England: S Godward (East Anglian Cancer Registry), MP Coleman (London School of Hygiene and Tropical Medicine), EMI Williams (Merseyside and Cheshire Cancer Registry), D Forman (Northern and Yorkshire Cancer Registry and Information Service), MJ Quinn (Office for National Statistics), M Roche, S Edwards (Oxford Cancer Intelligence Unit), C Stiller (Childhood Cancer Research Group, Oxford), J Verne (South West Cancer Intelligence Services), H Møller, J Bell (Thames Cancer Registry), JL Botha, (Trent Cancer Registry), G Lawrence (West Midlands Cancer Intelligence Unit); UK - Scotland: R Black (Scottish Cancer Intelligence Unit); UK - Wales: JA Steward (Welsh Cancer Intelligence and Surveillance Unit).

Received 7 August 2008 ,Revised 11 October 2008 ,Accepted 14 October 2008.

References 

  1. Major and minor salivary glands. In:  Rosai J editors. Ackerman’s Surgical Pathology. 9th ed.. St. Louis, Mo: Mosby; 2004;p. 873–916
  2. Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg. 1974;128(4):512–520
  3. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: a correlation of histologic features and clinical course. Cancer. 1978;42(1):265–282
  4. Nascimento AG, Amaral AL, Prado LA, Kligerman J, Silveira TR. Adenoid cystic carcinoma of salivary glands. A study of 61 cases with clinicopathologic correlation. Cancer. 1986;57(2):312–319
  5. Matsuba HM, Simpson JR, Mauney M, Thawley SE. Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation. Head Neck Surg. 1986;8(3):200–204
  6. Hamper K, Lazar F, Dietel M, Caselitz J, Berger J, Arps H, et al. Prognostic factors for adenoid cystic carcinoma of the head and neck: a retrospective evaluation of 96 cases. J Oral Pathol Med. 1990;19(3):101–107
  7. Huang M, Ma D, Sun K, Yu G, Guo C, Gao F. Factors influencing survival rate in adenoid cystic carcinoma of the salivary glands. Int J Oral Maxillofac Surg. 1997;26(6):435–439
  8. Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer. 2001;96(3):149–158
  9. Wiseman SM, Popat SR, Rigual NR, Hicks WL, Orner JB, Wein RO, et al. Adenoid cystic carcinoma of the paranasal sinuses or nasal cavity: a 40-year review of 35 cases. Ear Nose Throat J. 2002;81(8):510–514p. 516–517
  10. Friedrich RE, Bleckmann V. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients. Anticancer Res. 2003;23(2A):931–940
  11. Sung MW, Kim KH, Kim JW, Min YG, Seong WJ, Roh JL, et al. Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2003;129(11):1193–1197
  12. Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE. Adenoid cystic carcinoma of the head and neck – a 20 years experience. Int J Oral Maxillofac Surg. 2004;33(1):25–31
  13. Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD, Vilos GA, et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol. 2005;41(3):328–335
  14. Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma: factors influencing survival. Am J Surg. 1979;138(4):579–583
  15. Spiro RH. The controversial adenoid cystic carcinoma. Clinical considerations. In:  McGurk M,  Renehan AG editor. Controversies in the management of salivary gland disease. Oxford, UK: Oxford University Press; 2001;p. 207–211
  16. Berrino F, Capocaccia R, Coleman MP, Esteve J, Gatta G, Hakulinen T, et al. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol. 2003;14(Suppl. 5):
  17. World Health Organisation . International classification of diseases. 9th ed.. Geneva: WHO; 1975;
  18. World Health Organisation . International classification of diseases for Oncology (ICD-O). 2nd ed.. Geneva: WHO; 1990;
  19. Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, et al. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol. 2003;14(Suppl. 5):v14–v27
  20. Surveillance Research Program. National Cancer Institute SEER∗Stat software (www.seer.cancer.gov/seerstat) version 6.1.4.
  21. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;38:933–942
  22. Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P, et al. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol. 2003;14(Suppl. 5):V28–V40
  23. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51–64
  24. Stata Corp. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation; 2001.
  25. Tomich CE. Adenoid cystic carcinoma. In:  Ellis GL,  Auclair PL,  Gnepp DR editor. Surgical pathology of the salivary glands. Philadelphia, PA: Saunders; 1991;p. 333–349
  26. McKenna RJ. Clinical aspects of cancer in the elderly: treatment decision, treatment choices, and follow-up. Cancer. 1994;74(Suppl. 7):2107–2117
  27. Micheli A, Mariotto A, Giorgi RA, Gatta G, Muti P. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer. 1998;34:2271–2278
  28. Boyle P. Testicular cancer: the challenge for cancer control. Lancet Oncol. 2004;5:56–61
  29. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. European health systems and cancer care. Ann Oncol. 2003;14(5):v41–v60
  30. Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26:154–162
  31. Demicheli R, Valagussa P, Bonadonna G. Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy. Breast Cancer Res Treat. 2002;75:127–134

PII: S1368-8375(08)00311-4

doi: 10.1016/j.oraloncology.2008.10.010

Oral Oncology
Volume 45, Issue 8 , Pages 669-674 , August 2009

Article Tools

* Image Usage & Resolution